Catalyst Category

IND Filed

Live feed of every IND Filed catalyst in Regulatory and Clinical.

CATALYSTS IN FEED

167

AVG MAX MOVE

+101.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

Regulatory and ClinicalIND FiledJun 11, 2026 · 7:02am ET

PPBTPURPLE BIOTECH LTD.

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Company stated that IM1240 data support the first human study in 2027.

Regulatory and ClinicalIND FiledJun 11, 2026 · 7:02am ET

PPBTPURPLE BIOTECH LTD.+102.0%

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Regulatory and ClinicalIND FiledMay 8, 2026 · 7:31am ET

TRAWTraws Pharma, Inc.

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

Company to progress potential clinical candidates for Hantavirus infection.

Regulatory and ClinicalIND FiledMay 8, 2026 · 7:31am ET

TRAWTraws Pharma, Inc.+48.3%

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

Regulatory and ClinicalIND FiledMay 6, 2026 · 8:31am ET

IFRXInflaRx N.V.

InflaRx Announces Development of Izicopan for AAV Treatment

Company to focus on oral C5A receptor inhibitor for kidney disorder.

Regulatory and ClinicalIND FiledMay 6, 2026 · 8:31am ET

IFRXInflaRx N.V.+44.4%

InflaRx Announces Development of Izicopan for AAV Treatment

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Loading…

IND Filed

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

InflaRx Announces Development of Izicopan for AAV Treatment

InflaRx Announces Development of Izicopan for AAV Treatment

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

IND Filed

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Purple Biotech Presented New Cancer Immunotherapy Data at EACR 2026

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

Traws Pharma Announces Plans to Advance Hantavirus Treatment Candidates

InflaRx Announces Development of Izicopan for AAV Treatment

InflaRx Announces Development of Izicopan for AAV Treatment

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.